Glycosides

"Glycosides" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Any compound that contains a constituent sugar, in which the hydroxyl group attached to the first carbon is substituted by an alcoholic, phenolic, or other group. They are named specifically for the sugar contained, such as glucoside (glucose), pentoside (pentose), fructoside (fructose), etc. Upon hydrolysis, a sugar and nonsugar component (aglycone) are formed. (From Dorland, 28th ed; From Miall's Dictionary of Chemistry, 5th ed)

Descriptor ID	D006027
MeSH Number(s)	D09.408
Concept/Terms	Glycosides Glycosides

Below are MeSH descriptors whose meaning is more general than "Glycosides".

Chemicals and Drugs [D]
Carbohydrates [D09]
Glycosides [D09.408]

Below are MeSH descriptors whose meaning is related to "Glycosides".

Below are MeSH descriptors whose meaning is more specific than "Glycosides".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Glycosides" by people in this website by year, and whether "Glycosides" was a major or minor topic of these publications.

Bar chart showing 10 publications over 8 distinct years, with a maximum of 3 publications in 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2005	1	0	1
2009	0	1	1
2010	0	1	1
2018	1	0	1
2020	0	1	1
2021	1	0	1
2022	0	3	3
2024	1	0	1

Below are the most recent publications written about "Glycosides" by people in Profiles.

Weintraub WS, Kolm P, Dolman S, Alva M, Bhatt DL, Zhang Z. Cost-Effectiveness of Sotagliflozin in SOLOIST-WHF. JACC Heart Fail. 2024 Sep; 12(9):1600-1610.

View in: PubMed
Goje O, Sobel R, Nyirjesy P, Goldstein SR, Spitzer M, Faught B, Larson S, King T, Azie NE, Angulo D, Sobel JD. Oral Ibrexafungerp for Vulvovaginal Candidiasis Treatment: An Analysis of VANISH 303 and VANISH 306. J Womens Health (Larchmt). 2023 02; 32(2):178-186.

View in: PubMed
Nyirjesy P, Schwebke JR, Angulo DA, Harriott IA, Azie NE, Sobel JD. Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis. Clin Infect Dis. 2022 07 06; 74(12):2129-2135.

View in: PubMed
Schwebke JR, Sobel R, Gersten JK, Sussman SA, Lederman SN, Jacobs MA, Chappell BT, Weinstein DL, Moffett AH, Azie NE, Angulo DA, Harriott IA, Borroto-Esoda K, Ghannoum MA, Nyirjesy P, Sobel JD. Ibrexafungerp Versus Placebo for Vulvovaginal Candidiasis Treatment: A Phase 3, Randomized, Controlled Superiority Trial (VANISH 303). Clin Infect Dis. 2022 06 10; 74(11):1979-1985.

View in: PubMed
Sobel R, Nyirjesy P, Ghannoum MA, Delchev DA, Azie NE, Angulo D, Harriott IA, Borroto-Esoda K, Sobel JD. Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a?global phase 3, randomised, placebo-controlled superiority study (VANISH 306). BJOG. 2022 02; 129(3):412-420.

View in: PubMed
Petraitis V, Petraitiene R, Katragkou A, Maung BBW, Naing E, Kavaliauskas P, Barat S, Borroto-Esoda K, Azie N, Angulo D, Walsh TJ. Combination Therapy with Ibrexafungerp (Formerly SCY-078), a First-in-Class Triterpenoid Inhibitor of (1?3)-?-d-Glucan Synthesis, and Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis. Antimicrob Agents Chemother. 2020 05 21; 64(6).

View in: PubMed
Malatack JJ, Doyle D. A Drug Regimen for Progressive Familial Cholestasis Type 2. Pediatrics. 2018 01; 141(1).

View in: PubMed
Ye M, Zhao Y, Norman VL, Starks CM, Rice SM, Goering MG, O'Neil-Johnson M, Eldridge GR, Hu JF. Antibiofilm phenylethanoid glycosides from Penstemon centranthifolius. Phytother Res. 2010 May; 24(5):778-81.

View in: PubMed
Garo E, Hung CS, Williams RB, Olson KM, Hu JF, Rice SM, Hough GW, Goering MG, O'Neil-Johnson M, Eldridge GR, Starks CM. Dammarane-type triterpene glycosides from Oncoba manii active against methicillin-resistant Staphylococcus aureus. Planta Med. 2009 Apr; 75(5):541-3.

View in: PubMed
Grayson EJ, Ward SJ, Hall AL, Rendle PM, Gamblin DP, Batsanov AS, Davis BG. Glycosyl disulfides: novel glycosylating reagents with flexible aglycon alteration. J Org Chem. 2005 Nov 25; 70(24):9740-54.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement